SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-000161
Filing Date
2024-01-02
Accepted
2024-01-02 06:06:28
Documents
13
Period of Report
2023-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d575512d8k.htm   iXBRL 8-K 28954
2 EX-99.1 d575512dex991.htm EX-99.1 315834
  Complete submission text file 0001193125-24-000161.txt   532004

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20231227.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20231227_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20231227_pre.xml EX-101.PRE 10821
7 EXTRACTED XBRL INSTANCE DOCUMENT d575512d8k_htm.xml XML 3261
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 24500054
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)